Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

Lilly debuts more Foundayo data as FDA requests post-marketing trials

The regulator requires Lilly to evaluate the “unexpected serious” risks associated with Foundayo.

Annabel Kartal Allen

News

Amazon launches AI drug discovery platform

Abigail Beaney

News

FDA shares guide on genome editing best practices

Annabel Kartal Allen

News

Terremoto wins $108m in Series C to drive cancer and rare disease programmes

News

Boehringer Ingelheim and Zai Lab team up for dual DLL3 therapy study

News

Nucleai and Sirona Dx to provide new proteomics solution for pharma companies

News

Lilly to acquire CrossBridge Bio for up to $300m

News

J&J sets the tone for Q1 earnings with strong oncology growth

Analysis

Analyst Comment

Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment

GlobalData Healthcare

Comment

Advancing single-cell transcriptomics into the mainstream of biomedical research

Analyst Comment

In the face of tariffs, FDA-approved drug manufacturing deals are shifting to Europe

GlobalData Healthcare

Analyst Comment

HNSCC market is expected to reach to $4.5bn across 8MM by 2034

GlobalData Healthcare

Themes

Partner Content

Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design

In pharmaceutical and biopharmaceutical manufacturing, there is zero margin for error when it comes to process integrity and operator safety. Among the many variables that must be tightly controlled, pressure...

More themes

Partner Content

CinnaGen Enters EU Market with EMA Approval for Zandoriah®

News

Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer

Partner Content

Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential

Analyst Comment

First responders see AI and other advanced tech as essential

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape

$3495.00

Bio/Pharmaceutical Outsourcing Report, March 2026

$2950.00

Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

$17995.00

Venous Thromboembolism (VTE): Epidemiology Forecast to 2034

$9995.00

Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2026

$3450.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Amazon launches AI drug discovery platform

FDA shares guide on genome editing best practices

Terremoto wins $108m in Series C to drive cancer and rare disease programmes

Boehringer Ingelheim and Zai Lab team up for dual DLL3 therapy study

Nucleai and Sirona Dx to provide new proteomics solution for pharma companies

Lilly to acquire CrossBridge Bio for up to $300m

J&J sets the tone for Q1 earnings with strong oncology growth

Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment

Advancing single-cell transcriptomics into the mainstream of biomedical research

In the face of tariffs, FDA-approved drug manufacturing deals are shifting to Europe

HNSCC market is expected to reach to $4.5bn across 8MM by 2034

Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape

Bio/Pharmaceutical Outsourcing Report, March 2026

Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Venous Thromboembolism (VTE): Epidemiology Forecast to 2034

Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape

Bio/Pharmaceutical Outsourcing Report, March 2026

Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Venous Thromboembolism (VTE): Epidemiology Forecast to 2034

Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing